Zebra Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-83,652
Closed -$965K 262
2020
Q4
$965K Buy
83,652
+4,880
+6% +$44.6K 1.22% 11
2020
Q3
$600K Buy
+78,772
New +$597K 0.93% 29
2019
Q2
Sell
-31,881
Closed -$135K 530
2019
Q1
$135K Buy
31,881
+11,774
+59% +$48K 0.07% 399
2018
Q4
$82K Buy
20,107
+6,982
+53% +$36.4K 0.05% 365
2018
Q3
$90K Sell
13,125
-2,771
-17% -$16.4K 0.04% 407
2018
Q2
$62K Buy
+15,896
New +$55.1K 0.03% 327

Other funds holding CDMO

Zebra Capital Management's CDMO Position: Q1 2021 in Review

Zebra Capital Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2021, closing a stake of 83,652 shares — an estimated $965K sold.

Zebra Capital Management first reported a position in CDMO in Q2 2018 and held it in 6 quarters. The position peaked at $965K in Q4 2020. 158 funds tracked by Wall St. Rank hold CDMO as of Q1 2021.

  • Zebra Capital Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Zebra Capital Management sold 83,652 Avid Bioservices, Inc. Common Stock shares in Q1 2021, an estimated $965K.
  • Zebra Capital Management first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2018 and held it in 6 quarters.
  • Zebra Capital Management's Avid Bioservices, Inc. Common Stock position peaked at $965K in Q4 2020.
  • 158 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2021.

Based on Zebra Capital Management's 13F filing for Q1 2021, filed 17 May 2021.